The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

NCT02586168 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Insulin Sensitivity

Interventions

DRUG: Gemcabene 900 mg
DRUG: Placebo

Sponsor

NeuroBo Pharmaceuticals Inc.